Abstract: There is provided a rinse aid composition containing an organo diphosphonic acid or its salts or complexes. The pH of said composition as a 1% solution in distilled water at 20.degree. C. is preferably less than 7.

Abstract: A free-flowing granular detergent component or composition having a bulk density of at least 650 g/l comprises (i) at least 35% by weight of anionic surfactant; (ii) 0.5% to 10% by weight of a chelating agent; (iii) 0.5% to 30% by weight of a polymer or co-polymer wherein the weight ratio of chelating agent to polymer/copolymer is from 1:100 to 1:1. Additionally, processes for making the granular detergent component or composition comprise adding aqueous solutions of a chelating agent and a polymer or copolymer to a high active surfactant paste.

Abstract: A detergent composition comprises clay, a surfactant system and a copolymer of N-vinylimidazole and N-vinylpyrrolidone. The copolymer is present in the detergent composition in an amount of 0.01% to 10.0% by weight. The copolymer has an average molecular weight of from 5,000 to 50,000 and a molar ratio of N-vinylimidazole to N-vinylpyrrolidone of from 1:1 to 1:02.

Abstract: A detergent composition comprising a surfactant system substantially free of linear alkyl benzene sulfonate and a copolymer of N-vinylimidazole and N-vinylpyrrolidone. The copolymer is present in the detergent composition in an amount of 0.01% to 10.0% by weight and has an average molecular weight of from 5,000 to 1,000,000. The molar ratio of N-vinylimidazole to N-vinylpyrrilidone in the copolymer is from 1:1 to 1:0.2.

Abstract: The invention concerns laundry detergent compositions comprising lipase (especially the variant D96L of the native lipase derived from Humicola lanuginosa), protease, and surfactant, wherein said compositions comprise levels of lipase enzyme and protease enzyme such that the whitening performance of said compositions is increased. These compositions deliver an improved whiteness maintenance and/or dingy clean-up on fabrics.

Abstract: A process for preparing high density detergent compositions is provided. The process comprises the steps of: (a) continuously mixing a detergent surfactant paste and dry starting detergent material into a high speed mixer/densifier to obtain detergent agglomerates, wherein the ratio of the surfactant paste to the dry detergent material is from about 1:10 to about 10:1; (b) mixing the detergent agglomerates in a moderate speed mixer/densifier to further densify and agglomerate the detergent agglomerates; and (c) drying said detergent agglomerates so as to form the high density detergent composition. The dry detergent material may contain a builder material including a crystalline microstructure in which a carbonate anion, a calcium cation and at least one water-soluble cation are contained. The process may include one or more additional processing steps such as adding a coating agent such as the builder material described herein after the moderate speed mixer/densifier to facilitate and control agglomeration.

Abstract: A process is disclosed for the manufacture of a liquid detergent composition comprising a sulphiting agent and an enzyme system. Said enzyme system and said sulphiting agent interact together so as to generate odors which result in an odor deviation in said detergent composition. In the process of the invention, said enzyme system and said sulphiting agent are intimately mixed together separately from the remainder of the detergent composition so as to generate said odors outside the remainder of said detergent composition. Also disclosed is an enzyme premix consisting essentially of said enzyme system and said sulphiting agent.

Abstract: A granular laundry composition is disclosed which comprises a source of available-oxygen, a stabilizer like chelant together with an alkali metal salt of silicate. Such compositions allow to produced wash solutions wherein the bleaching activity is retained upon longer periods of time. Optionally said compositions may further comprise a soil suspender and be formulated so as to allow to keep the pH of the wash solution below 9.5 and thereby boost the cleaning performance on particulate soil (clay).

Abstract: The present invention relates to cleaning compositions comprising subtilisin proteases from Bacillus lentus having the following alterations: N76D, S103A and V104I, where the numbering is based on the corresponding positions in the subtilisin from Bacillus amyloliquefaciens.

Abstract: The present invention relates to a dishwashing, especially machine dishwashing, method wherein the articles to be washed are treated with an effective amount of a detergent composition comprising: A. a metallo catalyst selected from a) metallo porphin and water-soluble or water dispersable derivatives thereof; b) metallo porphyring and water-soluble or water-dispersable derivatives thereof; c) metallo phthalocyanine and water-soluble or water-dispersable derivatives thereof; and B. an enzymatic system capable of generating hydrogen peroxide.

Abstract: A method for hand washing dishes comprises contacting dishes with an aqueous solution containing polyhydroxy amine compound and one or more surfactant materials.

Abstract: A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals comprising fungicide is disclosed. The particular fungicide used is a 1,3-bis-triazolyl-2-propanol derivative. These compositions are also effective against viral infections.

Abstract: Laundry and cleaning compositions comprising a nonionic or anionic ester of an allylic alcohol perfume having the formula: ##STR1## especially geranyl and neryl esters.

Abstract: A process for purifying vitamin A consisting of heating a vitamin A preparation in an inert atmosphere, at a temperature below 170.degree. C. and a pressure of less than 4 mm of mercury, said heating taking place in a vessel shielded from light is disclosed. The vitamin A obtained from this process is mixed with from 0.5:1 to 2:1 parts of tocopherol to vitamin A. The vitamin A and tocopherol mixture can be encapsulated in acacia gum, starch, pectins or other suitable materials. When the vitamin A is encapsulated, the level of tocopherol required is less, preferably from 0.05:1 to about 1:1 parts of tocopherol to vitamin A is used in an encapsulated vitamin A composition. Other antioxidants can be added.

Abstract: Chilled or shelf stable beverage products which are physically stable, visually opaque and do not precipitate over time, and a process for preparing these products, are disclosed. These products contain from about 5 to about 99.8% milk, from about 0.05 to about 0.8% of a food stabilizer and a food acid. The first step of the process involves mixing milk with a food stabilizer under high shear mixing conditions to form protein/stabilizer particles having a median particle size of less than about 0.8 microns. Then, while still maintaining the particle size of the protein/stabilizer particles at less than about 0.8 microns, the protein/stabilizer mixture is acidified to a pH ranging from about 3.2 to about 4.5. In order to maintain the requisite particle size of the protein/stabilizer particles during the acidification step, the protein/stabilizer mixture is maintained under high shear mixing conditions at a temperature ranging from about 4 to about 30.degree. C.

Abstract: Polyol polyesters can be made by a transesterification reaction of a polyol with a lower alkyl fatty acid ester. A by product of that reaction are the alcohols from the lower alkyl esters. These are usually removed from the transesterification reaction by inert gas stripping. The process herein links the transesterification reaction with a lower alkyl ester formation reaction. The transesterification reaction acts as a the source of the lower alkyl alcohols for the formation of the lower alkyl esters used in the polyol fatty acid polyester synthesis. A preferred method for both reactions uses a reactive absorption column.

Abstract: A high density granular detergent composition having a pH (1% in distilled water) of from about 9.0 to about 10.0, that contains from 5% to about 50% anionic detergent surfactant and from about 3% to about 40% acid pyrophosphate is disclosed. The composition is formed by agglomeration of the acid pyrophosphate and a portion of the surfactant, preferably in a V-blender. The composition contains less than about 1%, but preferably is free of, citric acid.

Abstract: This invention is a pharmaceutical composition that inhibits the growth of cancers and tumors in mammals, particularly in human and warm blooded animals. The composition is also effective against viruses. The composition contains N-chlorophenylcarbamates and N-chlorophenylthiocarbamates which are systemic herbicides.

Abstract: The present invention relates to a method for stabilizing beverage fountain syrups having a dispersed oil phase consisting essentially of incorporating into said syrups from about 0.02% to about 0.3% of a stabilizer which is xanthan gum.The present invention further relates to beverage fountain syrup compositions, preferably dilute juice beverage fountain syrup compositions, comprising:a) from about 0.02% to about 0.3% of a stabilizer which is xanthan gum;b) from about 0.2% to about 3% oil:c) from about 0.2% to about 10% of an emulsifier which is a modified food starch;d) an effective amount of a flavor component:e) an effective amount of sweetener; andf) from about 30% to about 70% water;wherein said syrup has a Brix value of from about 30.degree. to about 70.degree. ; and a modified food starch to oil ratio of from about 0.1 to about 4.

Abstract: The present invention is directed to a novel enteric-coated oral dosage form of a risedronate active ingredient comprised of a safe and effective amount of a pharmaceutical composition which is comprised of a risedronate active ingredient and pharmaceutically-acceptable excipients. Said dosage forms prohibit the exposure of the risedronate active ingredient to the epithelial and mucosal tissues of the buccal cavity, pharynx, esophagus, and stomach and thereby protects said tissues from erosion, ulceration or other like irritation. Accordingly, the said dosage forms effect the delivery to the lower gastrointestinal tract of said human or other mammal of a safe and effective amount of the risedronate active ingredient, and substantially alleviate the esophagitis or esophageal irritation which occasionally accompanies the oral administration of risedronate active ingredients.